Compare HYPR & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HYPR | BHST |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medical Specialities | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.0M | 108.6M |
| IPO Year | N/A | N/A |
| Metric | HYPR | BHST |
|---|---|---|
| Price | $1.13 | $4.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $1.28 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 569.0K | 34.9K |
| Earning Date | 03-16-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $10,591,000.00 | ★ $32,720,000.00 |
| Revenue This Year | $5.96 | $116.40 |
| Revenue Next Year | $34.43 | $55.91 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 45.88 |
| 52 Week Low | $0.53 | $4.65 |
| 52 Week High | $2.22 | $12.80 |
| Indicator | HYPR | BHST |
|---|---|---|
| Relative Strength Index (RSI) | 50.65 | 42.33 |
| Support Level | $1.04 | $4.82 |
| Resistance Level | $1.18 | $5.04 |
| Average True Range (ATR) | 0.09 | 0.38 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 31.34 | 10.67 |
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.